Columbia, Missouri 65212


Purpose:

Elderberries (Sambuci fructus) have been shown in a number of studies to have significant anti-inflammatory and antioxidant effects. Multiple human and animal studies have supported the anti-inflammatory and antioxidant effects of elderberry preparations and it has been used in natural medicine for hundreds of years. Studies examining factors that may decrease the risk of Alzheimer's disease have revealed that drinking juices with similar properties to elderberries is one of the most reliable way to decrease risk. As such the investigators wish to determine the effects of elderberry juice on cognitive decline in a group of subjects at high risk for Alzheimer's disease, those with mild cognitive impairment. Elderberry juice is a commercially available nutritional supplement and easily available to this population.


Criteria:

Inclusion Criteria: - CDR score of 0.5 - MMSE of at least 24 - Age 50 or older Exclusion Criteria: - Known history of sensitivity to elderberry products. - Diabetes. - Bleeding disorder. - Current Pregnancy. - Known allergy to honeysuckle. - Currently making changes to other drugs that might affect cognitive performance (subjects showing the greatest cognitive decline and other signs of Alzheimer's disease may be prescribed cholinesterase inhibitors as this is a standard of care for Alzheimer's disease but not MCI). - Presence of any condition the health professional believes will impair ability to complete study procedures (ex. terminal illness, comorbid major psychiatric disorders such as schizophrenia, or drug abuse). - Potentially confounding neurodegenerative diseases (e.g. MS).


NCT ID:

NCT02414607


Primary Contact:

Principal Investigator
David Q Beversdorf, MD
University of Missouri-Columbia

David Q Beversdorf, MD
Phone: 573-882-6081
Email: beversdorfd@health.missouri.edu


Backup Contact:

Email: akh8c8@mail.missouri.edu
Allison Halt
Phone: 573-884-4263


Location Contact:

Columbia, Missouri 65212
United States

David Q Beversdorf, MD
Phone: 573-882-6081
Email: beversdorfd@health.missouri.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.